KIROMIC BIOPHARMA INC.

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	KRBP
ISIN:

KIROMIC BIOPHARMA INC. overview

KIROMIC BIOPHARMA INC. > News ACCESSWIRE published a news.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $50,000 to Contact the Firm • • ACCESSWIRE • Stocks • More KIROMIC BIOPHARMA INC. news...

LOS ANGELES, CA / ACCESSWIRE / August 26, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kiromic BioPharma, Inc. ("Kiromic" or "the Company") (NASDAQ:KRBP) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on July 2, 2021 (the "IPO"), and/or between June 25, 2021 and August 13, 2021, inclusive...

Thank you

KIROMIC BIOPHARMA INC. > News ACCESSWIRE published a news.

SHAREHOLDER DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses to Contact the Firm • • ACCESSWIRE • Stocks • More KIROMIC BIOPHARMA INC. news...

LOS ANGELES, CA / ACCESSWIRE / August 22, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kiromic BioPharma, Inc. ("Kiromic" or "the Company") (NASDAQ:KRBP) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on July 2, 2021 (the "IPO"), and/or between June 25, 2021 and August 13, 2021, inclusive...

Thank you

KIROMIC BIOPHARMA INC. > News ACCESSWIRE published a news.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm • • ACCESSWIRE • Stocks • More KIROMIC BIOPHARMA INC. news...

LOS ANGELES, CA / ACCESSWIRE / August 19, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kiromic BioPharma, Inc. ("Kiromic" or "the Company") (NASDAQ:KRBP) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on July 2, 2021 (the "IPO"), and/or between June 25, 2021 and August 13, 2021, inclusive...

Thank you

KIROMIC BIOPHARMA INC. > News ACCESSWIRE published a news.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm • • ACCESSWIRE • Stocks • More KIROMIC BIOPHARMA INC. news...

LOS ANGELES, CA / ACCESSWIRE / August 17, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kiromic BioPharma, Inc. ("Kiromic" or "the Company") (NASDAQ:KRBP) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on July 2, 2021 (the "IPO"), and/or between June 25, 2021 and August 13, 2021, inclusive...

Thank you

KIROMIC BIOPHARMA INC. > News ACCESSWIRE published a news.

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm • • ACCESSWIRE • Stocks • More KIROMIC BIOPHARMA INC. news...

LOS ANGELES, CA / ACCESSWIRE / August 10, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kiromic BioPharma, Inc. ("Kiromic" or "the Company") (NASDAQ:KRBP) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on July 2, 2021 (the "IPO"), and/or between June 25, 2021 and August 13, 2021, inclusive...

Thank you

KIROMIC BIOPHARMA INC. > Analyses

Londinia AI has published a new analysis for aba0550.

0
72415
15106
0

KIROMIC BIOPHARMA INC. - 1H

Timeframe : 1H - Simple chart
Status : TARGET REACHED

In the short term, there could be an acceleration of the basic bullish trend on KIROMIC BIOPHARMA INC.. This is a positive signal for buyers. As long as the price remains above 0.750 USD, a purchase…

Thank you Reply

KIROMIC BIOPHARMA INC. > Analyses

Londinia AI has published a new analysis for aba0550.

0
72415
15106
0

KIROMIC BIOPHARMA INC. - Daily

Timeframe : Daily - Simple chart
Status : INVALID

The bearish basic trend is very strong on KIROMIC BIOPHARMA INC. but the short term shows some signs of running out of steam. However, a sale could be considered as long as the price remains below…

Thank you Reply

KIROMIC BIOPHARMA INC. > Analyses

Londinia AI has published a new analysis for aba0550.

0
72415
15106
0

KIROMIC BIOPHARMA INC. - 1H

Timeframe : 1H - Simple chart
Status : TARGET REACHED

KIROMIC BIOPHARMA INC. is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 0.750 USD. The next…

Thank you Reply

Load more content